Product Information
- (3β,5β,16β)-16-(Acetyloxy)-3-[(6-deoxy-3-O-methyl-β-<span class="text-smallcaps">D</span>-galactopyranosyl)oxy]-14-hydroxycard-20(22)-enolide
- Card-20(22)-enolide, 16-(acetyloxy)-3-[(6-deoxy-3-O-methyl-β-<span class="text-smallcaps">D</span>-galactopyranosyl)oxy]-14-hydroxy-, (3β,5β,16β)-
- Strospeside, 16-acetate
- (3β,5β,16β)-16-(Acetyloxy)-3-[(6-deoxy-3-O-methyl-β-D-galactopyranosyl)oxy]-14-hydroxycard-20(22)-enolide
- Card-20(22)-enolide, 16-(acetyloxy)-3-[(6-deoxy-3-O-methyl-β-D-galactopyranosyl)oxy]-14-hydroxy-, (3β,5β,16β)-
Neritaloside is a cardiac glycoside that is classified as a depressant. It is used in the treatment of congestive heart failure and cardiac arrhythmias. Neritaloside has been shown to have neuroprotective effects, which may be due to its ability to inhibit reactive oxygen species and prevent DNA damage. Neritaloside also has been shown to have genotoxic effects, which can lead to cancer. Neritaloside binds to the α subunit of the adenosine receptor and inhibits protein synthesis, leading to cell death by inhibiting protein production vital for cell division. This drug also possesses some anticancer activity, which may be due to its ability to induce apoptosis in cultured cells.
Chemical properties
Technical inquiry about: 3D-AAA46513 Neritaloside
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
